Latest Cystic Fibrosis Trust Stories
Historic Time in Treatment of Cystic Fibrosis as Promising Drugs Reach Phase 3 Trials BETHESDA, Md., Oct. 8 /PRNewswire-USNewswire/ -- Francis S.
Legislation Would Remove Financial Penalties for Participating in Research Studies BETHESDA, Md., Sept.
Wedge Teams Up with 17-Year-Old Patient to "Pitch" Donations at Sept. 28 Game BETHESDA, Md., Sept. 25 /PRNewswire-USNewswire/ -- Eric Wedge, manager of the Cleveland Indians, is joining the fight against cystic fibrosis (CF), a fatal genetic disease.
Departing Chicago via Vespa Scooter, Schaller to Ride Through Seven Western States to Raise Awareness About CF BETHESDA, Md., Sept.
Bill would remove financial penalties for participating in research studies BETHESDA, Md., Sept.
SOUTH PLAINFIELD, N.J., Sept. 10 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 3 trial of ataluren (formerly PTC124(R)), an investigational protein restoration therapy in patients with nonsense mutation cystic fibrosis (nmCF).
BETHESDA, Md., Aug.
Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests.
BETHESDA, Md., July 9 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation commends the nomination by President Obama of Francis Collins, M.D., Ph.D., as the new director of the National Institutes of Health (NIH). "The CF Foundation is pleased that Dr.
Bill would remove financial penalties for participating in research studies BETHESDA, Md., June 15 /PRNewswire-USNewswire/ -- New legislation introduced today would allow patients with rare diseases to participate in clinical drug studies without losing their eligibility for government healthcare coverage. The "Improve Access to Clinical Trials Act" is co-sponsored by Representatives Edward J.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.